共 50 条
[38]
A DOUBLE-BLIND, PLACEBO CONTROLLED,PHASE II CHEMOIMMUNOTHERAPY (PACLITAXEL CARBOPLATIN-OREGOVOMAB) VS CHEMOTHERAPY (PACLITAXEL-CARBOPLATIN-PLACEBO) AS NEOADJUVANT THERAPY INPATIENTS WITH ADVANCED EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PERITONEAL CARCINOMA
[J].
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER,
2023, 33 (SUPPL_4)
:A251-A251